Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations

Loading...
Thumbnail Image
Authors
Halpin, David M
Journal
Clinical and Translational Allergy
Type
Journal Article
Publisher
Biomed Central
Rights
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Blood eosinophil count (BEC) and fractional exhaled nitric oxide (FeNO) concentration are established biomarkers in asthma, associated particularly with the risk of exacerbations. We evaluated the relationship of BEC and FeNO as complementary and independent biomarkers of severe asthma exacerbations.
Citation
Price DB [et al]. Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations. Clinical and Translational Allergy. 2019 Aug 21
Note
This article is freely available via Open Access. Click on the Publisher URL to access the full-text.